<--- Back to Details
First PageDocument Content
Organofluorides / Carbamates / Bristol-Myers Squibb / Amides / Darunavir / Atazanavir / Telaprevir / Efavirenz / Ritonavir / Chemistry / Organic chemistry / Protease inhibitors
Date: 2014-10-21 14:13:08
Organofluorides
Carbamates
Bristol-Myers Squibb
Amides
Darunavir
Atazanavir
Telaprevir
Efavirenz
Ritonavir
Chemistry
Organic chemistry
Protease inhibitors

Microsoft Word - Hepatitis C-int

Add to Reading List

Source URL: www.hcvdruginfo.ca

Download Document from Source Website

File Size: 209,48 KB

Share Document on Facebook

Similar Documents

KULLANMA TALİMATI VIEKIRAX 12,5 mg / 75 mg / 50 mg film kaplı tablet Ağız yolu ile alınır. • Etkin madde: Her bir film kaplı tablet 12,5 mg ombitasvir ve 75 mg paritaprevir ve 50 mg ritonavir içerir. • Yardı

DocID: 1vovV - View Document

DRUG Interactions with HIV MEDICATIONS Ritonavir used to be given in higher amounts than it is now. (now it is mostly used to boost other HIV Meds). The old, higher dose dramatically raised levels of drugs in the body to

DocID: 1tONr - View Document

MEDICATION GUIDE VIEKIRA XR (vee-KEE-rah-XR) (dasabuvir, ombitasvir, paritaprevir, and ritonavir) extended-release tablets for oral use Important: When taking VIEKIRA XR in combination with ribavirin, you should also rea

DocID: 1sPr9 - View Document

Breakthrough therapy / Chemistry / Pharmaceutical sciences / Carbamates / Pharmacology / Pyrrolidines / Ombitasvir/paritaprevir/ritonavir / Ritonavir / Ombitasvir / AbbVie Inc. / Paritaprevir / Kidney

Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio

DocID: 1qWZQ - View Document

Chemistry / Medicine / Clinical medicine / Breakthrough therapy / Carbamates / Cyclopropanes / Infectious causes of cancer / Sulfonamides / Simeprevir / Sofosbuvir / Ombitasvir/paritaprevir/ritonavir / Telaprevir

Treatment of Chronic Hepatitis C - January 2016 Update (The changes compared to the November 2015 Update are highlighted in yellow) Swiss Association for the Study of the Liver and Swiss Society for Infectious Diseases

DocID: 1qOAQ - View Document